Investments in new microbiome therapies as medicinal products continue to be on the rise and are attracting large Consumer Health ...

Many pharma and biotech businesses implement lean Six Sigma (LSS) practices to lower their operational costs and provide high quality ...

The value that comes from patient journey mapping exercises is well-established in the life sciences industry. These activities are focused ...

The predominate focus of an early stage life sciences on their path to commercialization is on two fronts. The first ...

With a slow, long, and regulated road to successful drug development, along with standard approval gates required for progression, the ...

Defining how your sales force will be organized is a critical task leading up to new pre-commercial product launch. Traditionally, ...

With much of the world focused on the response to COVID-19, many biopharmaceuticals are looking at new ways that they ...

On January 28, 2020, the highly anticipated final FDA gene therapy guidances were released. In total, 7 guidance documents were ...

The 2020 pharmaceutical trends reflect the broad shifts currently impacting the industry as it moves from the blockbuster model that ...

Numerous channels are competing for physician awareness now, making the process for modern drugmakers all the more challenging in fostering ...

Increased globalization and the growing complexities around innovative, next-generation therapies has forced biopharmaceutical leaders to reexamine their clinical supply chain ...

In the age of precision and personalized medicine, life science companies can develop treatments designed to target almost any patient’s ...